Skip to main content
Vir Biotechnology, Inc. logo

Vir Biotechnology, Inc. — Investor Relations & Filings

Ticker · VIR ISIN · US92764N1028 US Manufacturing
Filings indexed 727 across all filing types
Latest filing 2021-02-11 Major Shareholding Noti…
Country US United States of America
Listing US VIR

About Vir Biotechnology, Inc.

https://www.vir.bio/

Vir Biotechnology, Inc. is a clinical-stage immunology company that leverages the immune system to treat and prevent serious infectious diseases and other conditions. The company's pipeline is built on two primary technology platforms: a next-generation antibody platform for identifying and optimizing therapeutic candidates, and the PRO-XTEN® protease-releasable masking technology for applications in oncology. Vir's main therapeutic area is infectious diseases, featuring a leading program for chronic hepatitis delta, and is complemented by strategic programs in oncology. The company has demonstrated its capabilities by developing antibody-based medicines for significant health challenges, including COVID-19 and Ebola.

Recent filings

Filing Released Lang Actions
SC 13G/A
Major Shareholding Notification
2021-02-11 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-10 English
FORM 4 SUBMISSION
Director's Dealing
2021-02-03 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes references to press releases about clinical trial data and collaborations, attached as exhibits. There are no financial statements or detailed financial data presented. The document is short (4174 characters) and primarily serves as an announcement of events and press releases rather than a full financial or management report. Therefore, it fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other specific categories.
2021-01-28 English
FORM 4 SUBMISSION
Director's Dealing
2021-01-28 English
FORM 4 SUBMISSION
Director's Dealing
2021-01-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.